Background: Current data on the use of irreversible electroporation (IRE) in the treatment of
prostate cancer (PCa) is limited. We aim to evaluate the safety, short-term functional and …

Background: To evaluate the safety and clinical feasibility of focal irreversible
electroporation (IRE) of the prostate. Methods: We assessed the toxicity profile and …

Objectives To determine the safety, quality of life (QoL) and short‐term oncological
outcomes of primary focal irreversible electroporation (IRE) for the treatment of localized …

Objectives To evaluate longer‐term oncological and functional outcomes of focal irreversible
electroporation (IRE) as primary treatment for localised clinically significant prostate cancer …

Background Current surgical and ablative treatment options for prostate cancer (PCa) may
result in a high incidence of (temporary) incontinence, erectile dysfunction and/or bowel …

Although it can be lethal in its advanced stage, prostate cancer can be effectively treated
when it is localised. Traditionally, radical prostatectomy (RP) or radiotherapy (RT) were used …

Introduction Focal therapy may reduce the toxicity of current radical treatments while
maintaining the oncological benefit. Irreversible electroporation (IRE) has been proposed to …

Background Irreversible Electroporation (IRE) is a novel image-guided tissue ablation
technology that induces cell death via very short but strong pulsed electric fields. IRE has …

Background Focal irreversible electroporation (IRE) can be used to treat men with localised
prostate cancer (PCa) with reduced impact on quality of life (QoL). Objective To assess …

Background Irreversible electroporation (IRE) is a nonthermal ablative method based on the
formation of nanoscale defects in cell membranes leading to cell death. Clinical experience …